Priority review for Welireg is based on data from the Phase II LITESPARK-015 trial, which showed promising response rates in patients with advanced, unresectable, or metastatic pheochromocytoma and ...

The FDA has accepted the application for belzutifan for advanced, unresectable, or metastatic pheochromocytoma and paraganglioma.

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025.

The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma.

b Performed 3 months later at the outpatient clinic. c For conversion to mg/dl divide by 0.0555. d For conversion to mg/dl divide by 88.4. a Performed at presentation. b Performed 3 months later ...

Associated symptoms such as fever, night sweats, or weight loss should be considered red flags and require further investigation for causes of secondary hyperhidrosis.

A team led by the Cancer Immunogenomics group at the Josep Carreras Leukaemia Research Institute, the Computational Biology group at the Barcelona Supercomputing Center and the Germans Trias i Pujol ...

The disease is hallmarked by the abnormal production of hemoglobin, which causes chronic anemia and can lead to other complications. Pyruknd won its first approval in 2022 for pyruvate kinase (PK ...

A deadly collision between an Army helicopter and a commercial airplane at Ronald Reagan National Airport in Washington has claimed 67 lives, including Indian-origin passengers Vikesh Patel and ...

White House press secretary Karoline Leavitt announced that tariffs on Canada and Mexico will begin on February 1, as decided earlier dismissing reports that claimed the tariffs will be deferred ...